JP2014524921A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014524921A5 JP2014524921A5 JP2014520787A JP2014520787A JP2014524921A5 JP 2014524921 A5 JP2014524921 A5 JP 2014524921A5 JP 2014520787 A JP2014520787 A JP 2014520787A JP 2014520787 A JP2014520787 A JP 2014520787A JP 2014524921 A5 JP2014524921 A5 JP 2014524921A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- following formula
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical class CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 229940126062 Compound A Drugs 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 0 *c1ccc(C[C@@](Cc2ccccc22)([C@@]2O)C2=Cc3ccccc3C2)cc1 Chemical compound *c1ccc(C[C@@](Cc2ccccc22)([C@@]2O)C2=Cc3ccccc3C2)cc1 0.000 description 1
- MBBZMMPHUWSWHV-UHFFFAOYSA-O C[NH2+]CC(C(C(C(CO)O)O)O)O Chemical compound C[NH2+]CC(C(C(C(CO)O)O)O)O MBBZMMPHUWSWHV-UHFFFAOYSA-O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161510628P | 2011-07-22 | 2011-07-22 | |
| US61/510,628 | 2011-07-22 | ||
| PCT/IE2012/000037 WO2013014659A1 (en) | 2011-07-22 | 2012-07-20 | Indene derivatives for use in the treatment of inflammatory bowel disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014524921A JP2014524921A (ja) | 2014-09-25 |
| JP2014524921A5 true JP2014524921A5 (enExample) | 2015-05-07 |
| JP5898768B2 JP5898768B2 (ja) | 2016-04-06 |
Family
ID=46584089
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014520787A Expired - Fee Related JP5898768B2 (ja) | 2011-07-22 | 2012-07-20 | 炎症性腸疾患の治療に使用するためのインデン誘導体 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US9586885B2 (enExample) |
| EP (1) | EP2734496A1 (enExample) |
| JP (1) | JP5898768B2 (enExample) |
| CN (1) | CN103764608B (enExample) |
| AU (1) | AU2012288404A1 (enExample) |
| BR (1) | BR112014001551A2 (enExample) |
| CA (1) | CA2839606A1 (enExample) |
| NZ (1) | NZ618936A (enExample) |
| RU (1) | RU2601307C2 (enExample) |
| TW (1) | TWI537246B (enExample) |
| WO (1) | WO2013014659A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013014660A1 (en) * | 2011-07-22 | 2013-01-31 | Venantius Limited | Indane dimers for use in the treatment of autoimmune inflammatory disease |
| CN110426464B (zh) * | 2019-07-08 | 2022-03-04 | 苏州正济药业有限公司 | 一种葡甲胺中异构体的hplc检测方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2322859A (en) * | 1995-12-06 | 1998-09-09 | Venantius Limited | Indane compounds with smooth muscle relaxing and/or mast cell stabilising and/or anti-inflammatory activity |
| DE19619036A1 (de) | 1996-04-30 | 1997-11-13 | Schering Ag | Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
| AU3899097A (en) * | 1996-08-05 | 1998-02-25 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted aromatic compounds |
| EP1032385A1 (en) * | 1997-11-20 | 2000-09-06 | Children's Medical Center Corporation | Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cellproliferation, diarrhe and scours |
| US20020128256A1 (en) * | 1997-11-20 | 2002-09-12 | Carlo Brugnara | Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferation |
| ES2240201T3 (es) * | 1999-10-20 | 2005-10-16 | Tanabe Seiyaku Co., Ltd. | Inhibidores de la adhesion molecular mediada por la alfa-l beta-2. |
| DE602004031410D1 (de) | 2003-04-15 | 2011-03-31 | Aquinox Pharmaceuticals Inc | Inden derivate als pharmazeutika |
| US7592461B2 (en) * | 2005-12-21 | 2009-09-22 | Bristol-Myers Squibb Company | Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof |
| WO2013014660A1 (en) | 2011-07-22 | 2013-01-31 | Venantius Limited | Indane dimers for use in the treatment of autoimmune inflammatory disease |
| EP2864279B1 (en) | 2012-05-24 | 2016-11-02 | Venantius Limited | Compounds for use in the treatment of autoimmune inflammatory disease |
| EP2855416A1 (en) | 2012-05-24 | 2015-04-08 | Venantius Limited | Indane dimers for use in the treatment of autoimmune inflammatory disease |
-
2012
- 2012-07-20 TW TW101126409A patent/TWI537246B/zh not_active IP Right Cessation
- 2012-07-20 WO PCT/IE2012/000037 patent/WO2013014659A1/en not_active Ceased
- 2012-07-20 CN CN201280035083.7A patent/CN103764608B/zh not_active Expired - Fee Related
- 2012-07-20 AU AU2012288404A patent/AU2012288404A1/en not_active Abandoned
- 2012-07-20 JP JP2014520787A patent/JP5898768B2/ja not_active Expired - Fee Related
- 2012-07-20 EP EP12740702.1A patent/EP2734496A1/en not_active Withdrawn
- 2012-07-20 RU RU2013155270/04A patent/RU2601307C2/ru not_active IP Right Cessation
- 2012-07-20 CA CA2839606A patent/CA2839606A1/en not_active Abandoned
- 2012-07-20 US US14/124,937 patent/US9586885B2/en not_active Expired - Fee Related
- 2012-07-20 BR BR112014001551-1A patent/BR112014001551A2/en not_active IP Right Cessation
- 2012-07-20 NZ NZ618936A patent/NZ618936A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014507446A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| ME02321B (me) | Antivirusna jedinjenja | |
| JP2011528713A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| JP2016508134A5 (enExample) | ||
| JP2017524735A5 (enExample) | ||
| JP2016536286A5 (enExample) | ||
| JP2011102304A5 (enExample) | ||
| JP2010077141A5 (enExample) | ||
| JP2015501783A5 (enExample) | ||
| JP2016515561A5 (enExample) | ||
| JP2014508804A5 (enExample) | ||
| JP2016510326A5 (enExample) | ||
| HRP20171648T1 (hr) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| JP2011527299A5 (enExample) | ||
| JP2019516739A5 (enExample) | ||
| JP2015502926A5 (enExample) | ||
| JP2015516419A5 (enExample) | ||
| JP2015509075A5 (enExample) | ||
| PH12015501945B1 (en) | Formulations of organic compounds | |
| RU2017141536A (ru) | Замещенные производные индол-5-ола и их терапевтические применения | |
| ME02405B (me) | Spojevi pirazola као inhibitori sglt1 | |
| JP2016515550A5 (enExample) |